Paton NI, Gurumurthy M, Lu Q, Leek F, et al. Adjunctive pascolizumab in rifampicin-susceptible pulmonary tuberculosis: proof-of-concept, partially-randomised, double-blind, placebo-controlled, dose-escalation trial. J Infect Dis 2024 Mar 25:jiae104. doi: 10.1093.
PMID: 38527849